METABOLIC RATIOS OF LANSOPRAZOLE TO 5-HYDROXYLANSOPRAZOLE AND LANSOPRAZOLE TO LANSOPRAZOLE SULFONE FOR PREDICTION OF CYP2C19 AND CYP3A4 METABOLIC ACTIVITY

Investor logo
Authors

JUŘICA Jan KOSTOLANSKÁ Katarína PEŠ Ondřej HLINOMAZ Ota MÁCHAL Jan

Year of publication 2017
Type Conference abstract
Citation
Description lansoprazol as a probe drug of human CYP2C19, CYP3A4 metabolic activity in clinical settings
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.